Article
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 1 Jun 2004
MacPhee Iain A M, Fredericks Salim, Tai Tracy, Syrris Petros, Carter Nicholas D, Johnston Atholl, Goldberg Lawrence, Holt David W
Abstract excerpt
Previously, we reported that, at 3 months after renal transplantation, individuals with CYP3AP1 genotype CYP3AP1*1 (linked to CYP3A5*1 and strongly associated with expression of CYP3A5) required twofold higher doses of tacrolimus to achieve target blood concentrations than individuals with the genotype CYP3AP1*3/*3 (CYP3A5 nonexpressors). This study assesses the relationship between concentration-controlled...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
